Drug-pricing – medicarereport.org

A trusted source for Medicare news and education from the AMAC Foundation.

The 10 drugs that CMS might wrangle into negotiations

(By Paige Twenter for Becker’s Hospital Review ) CMS plans to soon release its list of 10 drugs that are

Eileen Cook August 16, 2023August 16, 2023 CMS, Drug-pricing, Medicare Drug Price Negotiation Program, Medicare Part D

Health Care Finance Health Care Redesign Part D/Prescription Drugs

This Panel Will Decide Whose Medicine to Make Affordable. Its Choice Will Be Tricky

(By Markian Hawryluk for KFF Health News) Catherine Reitzel’s multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies

Eileen Cook May 25, 2023May 25, 2023 Affordable Medicine, Drug-pricing, Healthcare Costs

FDA Health Care Finance Legislative Update Part D/Prescription Drugs

PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention

(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the

Eileen Cook May 11, 2023 Drug-pricing, Legislation, PBM Industry, pharmaceuticals

Affordable Care Act (ACA)Employer Healthcare Health Care Redesign Health Insurance Legislative Update Part D/Prescription Drugs

How Medicare drug pricing changes could affect commercial plans: 3 things to know

(By Rylee Wilson for Becker’s Hospital Review ) The drug-pricing provisions of the Inflation Reduction Act only apply directly to

Eileen Cook December 15, 2022December 15, 2022 Drug-pricing, Employer Health Insurance, Higher out-of-pocket expense, Inflation Reduction Act of 2022, medicare